Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability.
Neuron
; 25(2): 359-71, 2000 Feb.
Article
in En
| MEDLINE
| ID: mdl-10719891
ABSTRACT
We have combined genetic and biochemical approaches to analyze the function of the RNA-binding protein Nova-1, the paraneoplastic opsoclonus-myoclonus ataxia (POMA) antigen. Nova-1 null mice die postnatally from a motor deficit associated with apoptotic death of spinal and brainstem neurons. Nova-1 null mice show specific splicing defects in two inhibitory receptor pre-mRNAs, glycine alpha2 exon 3A (GlyRalpha2 E3A) and GABA(A) exon gamma2L. Nova protein in brain extracts specifically bound to a previously identified GlyRalpha2 intronic (UCAUY)3 Nova target sequence, and Nova-1 acted directly on this element to increase E3A splicing in cotransfection assays. We conclude that Nova-1 binds RNA in a sequence-specific manner to regulate neuronal pre-mRNA alternative splicing; the defect in splicing in Nova-1 null mice provides a model for understanding the motor dysfunction in POMA.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ribonucleoproteins
/
RNA-Binding Proteins
/
Alternative Splicing
/
Motor Neurons
/
Antigens, Neoplasm
/
Nerve Tissue Proteins
Limits:
Animals
Language:
En
Journal:
Neuron
Journal subject:
NEUROLOGIA
Year:
2000
Type:
Article
Affiliation country:
United States